Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab

Authors:

Bullement A, D’Angelo SP, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A and Bharmal M.

Publication type:

Journal article

Publication name:

Journal of Clinical Oncology

Citation:

Bullement A, D’Angelo SP, Amin A, Stapelkamp C, Willis A, Lilley C, Hatswell A and Bharmal M. Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab. J Clin Oncol. 2018; 36(15_suppl):e21620-e.

Link to publication ⟶

h4>⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies